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Background: Tuberculous is the leading cause of death worldwide with a large number of deaths occurring in
developing countries. Tuberculous lymphadenitis is among the most common presentations of extra pulmonary
tuberculous. This study attempts to determine the magnitude of tuberculous lymphadenitis from patients with
lymph node aspirate in Gondar University Hospital, Northwest Ethiopia.
Methods: Retrospective study was conducted. Data were collected from registration book of Gondar university
Hospital pathology laboratory after checking the completeness of patient’s necessary information like age, sex and
fine needle aspiration cytology results. Data were entered and analyzed using SPSS version 16 statistical package.
Chi-square test was done to determine associations.
Result: A total of 3,440 lymph node aspirates were examined using fine needle aspiration cytology. Of these, 2,392
(69.5%) cases were found to have tuberculous lymphadenitis. Male 1647(47.9%) to female 1793(52.1%) ratio of all
study subjects were 0.9:1. Females (54.1%) were more affected than males (45.9%). Age, sex and site of aspiration
were found to be statistically associated with tuberculous lymphadenitis (p-value < 0.001). The age group of 15–24
years had the highest prevalence of tuberculous lymphadenitis followed by those of 25–34 years old. The most
affected sites were cervical lymph nodes (47.5%) followed by auxiliary (19.4%) and submandibular (12.9%) lymph
node regions. None of the records documented the HIV status of subjects.
Conclusion: The prevalence of tuberculous from lymph node aspirate was found to be higher involving the
frequently affected site of cervical lymph node. The HIV status of patients with all forms of tuberculous should have
to be checked and documented. Further prospective and advanced studies are recommended to determine the
specific etiologic agents and contributing factors.
Keywords: Tuberculous lymphadenitis, Fine needle aspiration cytology, EthiopiaBackground
Tuberculous (TB) is a chronic bacterial disease caused
by a slightly curved non motile, aerobic, non-capsulated
and non-spore forming strains of mycobacteria usually
Mycobacterium tuberculous [1]. It is a major public
health problem in the world and 1/3 of world’s popula-
tion is infected predominantly in developing countries
[2]. The magnitude of TB is higher in the developing
world due to various factors including malnutrition, dif-
ferent causes of immune suppression, dual HIV-TB epi-
demic and increasing causes of drug resistant TB (Multi
drug resistant TB (MDRTB), Extreme drug resistant TB* Correspondence: dagne24@gmail.com
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reproduction in any medium, provided the or(X-DRTB)) [3]. Ethiopia ranks 7th in the list of 22 high
burdens countries severely affected by tuberculous [4].
As per WHO global TB report of 2012, the estimated in-
cidence of all forms of TB in Ethiopia was 220/100,000
population [5] and smear positive cases was 63/100,000
population [6].
Extra pulmonary tuberculous (EPTB) affects different
organs of human body where tuberculous lymphadenitis
(TBLN) is the most common manifestations of all EPTB
[7-10]. The most commonly involved lymph nodes were
cervical, axilliary, inguinal, abdominal and supra clavicu-
lar sites. Cervical lymph nodes are the most commonly
affected group of nodes [11]. Tuberculous that affects
cervical lymph nodes represents about 50% of EPTB
even though it could vary in different areas [12]. ALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Distribution of patients with tuberculous
lymphadenitis by sex, age and site of aspiration in
Gondar University Hospital from January, 2003– January,
2007 and January, 2010– January, 2011 G.C.
Variables Tuberculous lymphadenitis X2 P
valuePositive (%) Negative (%)
Age 10.402 <0.001
<5 108(4.5) 113 (10.4)
5-14 296 (12.6) 221 (21.1)
15-24 682 (28.5) 255 (24.3)
25-34 660 (27.6) 246 (23.5)
35-44 347 (14.5) 119 (11.4)
≥45 299 (12.5) 94 (9.0)
Sex 12.271 <0.001
Male 1098 (45.9) 549 (52.4)
Female 1294 (54.1) 499 (47.6)
Site of aspiration 65.749 <0.001
Cervical 1135 (47.4) 423 (40.4)
Axillary 463 19.4) 272 (28.0)
Inguinal 150 (6.3) 60 (5.7)
Supraclavicular 208 (8.7) 43 (4.1)
Submandibular 308 (12.9) 182 (17.4)
Auricular 15 (0.6) 12 (1.1)
Neck 100 (4.2) 40 (3.8)
Others 13 (0.5) 16 (1.5)
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lous lymphadenitis among patients in different areas
[13-16]. In a study conducted in the rural part of
Ethiopia, 72.8% cases of TBLN were found [17] and the
cervical region was the most affected site (74.2%)
followed by the axillaries and inguinal lymph node re-
gions, 20.3% and 4.3%, respectively [18].
In Ethiopia, there are only few reports concerning
TBLN. Particularly in Gondar there is no data that
shows the magnitude of TBLN. This study attempts to
assess the magnitude of TBLN and provide baseline in-
formation for health professionals and other concerned
bodies. Therefore, the aim of the study was to assess
magnitude of TBLN from patients with lymph node as-
pirate in Gondar University Hospital.
Methods
A retrospective study of seven years period from January,
2003 to January, 2007 and January, 2010 to January 2011
was carried out in Gondar University Hospital pathology
laboratory registration book. Gondar is found in North
West part of Ethiopia, with in the Amhara regional state
at about 748 and 175 kilometers away from the capital
Addis Ababa and Bahir Dar respectively. The population
of the town is about 206,987 as stated in central statis-
tical agency (CSA) of Ethiopia, 2007.
The study populations were all patients with lymph
node aspirate in Gondar University Hospital. The study
subjects were all patients with lymph node aspirate be-
tween January, 2003 and January, 2007 and January, 2010
to January, 2011. All patients with lymph node aspirate
between January, 2003 to January, 2007 and January, 2010
to January, 2011 were included in the study by collecting
data from the registration book. Records with incomplete
data and demographic characteristics were excluded.
TBLN diagnosis by cytology was made by examination of
the presence of caseous necrosis, epitheloid cell granu-
lomas, multi nucleated giant cells, degenerated epithelioid
cell with neutrophil and hetrogeneous lymphoid popula-
tion plus granulomatous features.
Data were collected by investigators from registration
book of Gondar university Hospital pathology laboratory
after checking the completeness of patient’s necessary in-
formation like age, sex and fine needle aspiration cytology
results. Data were analyzed using SPSS version 16 statis-
tical package. Data were summarized using descriptive
statistics. Association was done using Chi-square test and
P-value <0.05 were considered statistically significant.
Ethical consideration
Data were collected after ethical clearance obtained from
the School of Biomedical and Laboratory Sciences,
College of Medicine and Health Science, University of
Gondar. After discussing the purpose and aim of thestudy, permission was obtained from the Head of
Gondar University Hospital pathology laboratory before
the data collection.
Result
A seven year period retrospective study was carried out
to determine the prevalence of tuberculous lymphaden-
itis among patients examined by FNAC at Gondar Uni-
versity Hospital pathology laboratory. A total of 3,440
lymph node aspirates were examined. Out of these,
2,392 (69.5%) were found to have cytological findings
suggestive of TBLN and 1,048 (30.5%) cases were diag-
nosed as reactive lymphadenitis. Male 1,647 (47.9%) to
female 1,793 (52.1%) ratio of all study subjects were
0.9:1. Tuberculous lymphadenitis was found among
1,098 (45.9%) males and 1294 (54.1%) females with an
overall prevalence of 69.5% (Table 1). Females are rela-
tively more affected than males. Higher proportion of
tuberculous lymphadenitis were found among the age
group of 15–24 years (28.5%) and 25–34 years (27.6%)
(Table 1). The most affected sites were cervical lymph
nodes 1135 (47.5%); axilliary 463 (19.4%) and subman-
dibular 308 (12.9%). The least affected lymph node sites
were the auricular, neck and other sites with 6%, 4.2%
and 0.5% respectively (Figure 1).
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Figure 1 Prevalence of tuberculous lymphadenitis by Site of aspiration among patients with lymph node aspirate in Gondar
University Hospital from January, 2003– January, 2007 and January, 2010– January, 2011 G.C.
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ating from 234 to 781 cases. The trend has continued
with no great difference in 2003 and 2004 with a total of
623 and 582 TBLN cases but lower in the year 2005 and
2006 that was 453 and 234 cases respectively. In the year
2007, 2010 and 2011, the occurrence rises to 280, 487
and 781 cases respectively (Figure 2).
Age, sex and Site of aspiration were found to be sig-
nificantly associated with TBLN. The age group of 15–
24 years had the highest prevalence 682 (28.5%) followed
by those of 25–34 years with 660 (27.6%) and 35–44
years with 347 (14.5%) and >45 years with 299 (12.5%)
(P-value < 0.001). Tuberculous lymphadenitis was higher
in females than males with statistically significant differ-
ence (p-value < 0.001). The most affected sites were
cervical lymph nodes, axillary and submandibular with
statistically significant difference (p-value < 0.001) (Table 1).
None of the records documented the HIV status of
patients.Figure 2 Trend prevalence of tuberculous lymphadenitis among patie
January, 2003– January, 2007 and January, 2010– January, 2011 G.C.Discussion
The prevalence of tuberculous lymphadenitis has been
reported to be higher in developing countries like
Ethiopia compared to developed countries [2]. In this
study, the prevalence of TBLN was 69.5% which is iden-
tical with other study done in Tanzania with prevalence
of 69.5% [14]. Other studies in Israel, Ethiopia and India
showed similar figure with prevalence of 70%, 72.8% and
73.75% [17,19,20] but to some extent higher in another
Indian study with prevalence of 83% [11]. The higher
prevalence in this Indian study could be due to the sam-
ple size and the time of study where awareness of TB
was poor years ago. In contrast to this study, the preva-
lence of TBLN was lower in Nigeria (24.45%), Pakistan
(44%) and India (62%) [13,15,21]. This difference could
be due to the different study methods used where small
sample size was used in Pakistan and in India. In
addition, these studies were onetime studies while our
study is retrospective study.nts with lymph node aspirate in Gondar University Hospital from
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ment of younger patients with 15–24 years old being af-
fected accounting 28.5% followed by 25–34 years old
accounting 27.6% of the cases. This finding is similar to
other studies where younger than 30 years old are the
commonest age group affected by this disease [18]. Simi-
lar study in Nigeria showed the age group of 10–19
years old with highest prevalence (28.1%) and 20–29
years with 21.8% which is consistent with our study but
the magnitude of the age group 0–9 years has prevalence
of 26.3% which is higher than our study [15]. Male to fe-
male ratio of our study is found to be 0.9:1 in which fe-
males being highly affected than males with no obvious
preponderance in Israel, Pakistan, Nigeria, Ethiopia
[11,15,18,19]. Cervical lymph node was found to be the
most commonly affected site (47.5%) compared to axil-
laries and other affected sites. This finding is in agree-
ment with the previous study done in Ethiopia where
cervical regions (74.2%) being mostly affected site
followed by axillary (20.3%) and inguinal regions (4.3%)
[18] and the study in India and Nigeria were also re-
vealed similar manner [15,21]. Historically, tuberculous
cervical lymphadenitis has been more common in chil-
dren and young adults [22].
The trend prevalence of TBLN cases in this study was
variable over the years revealing increment in the recent
years. The variation in patterns of prevalence of TBLN
might be due to TB-HIV co-infection, other immune
compromization (chronic diseases) that causes immune
suppression and increased risk of developing tubercu-
lous, awareness of people about early diagnosis and
treatment of TB patients. Especially in 2003 and 2004
before the era of anti retroviral therapy, the numbers of
cases were higher compared to 2005 and 2006. The rea-
son for decreased prevalence in the two consecutive
years could be due to lack of service expansion in the
hospital hence patients were appointed for more than a
month and cannot come back to the hospital. In 2007,
2010 and 2011, there was slight increment in number of
cases. This might be due to the increased awareness of
community about tuberculous and get diagnosed than
the previous years. Increased cases of malnutrition,
chronic diseases and MDR-TB could also exaggerate the
rate of TBLN in these recent years. The other reason
could be increased patient health seeking behavior, ser-
vice expansion where patients were not appointed not
more than a week, well equipped laboratory service and
increased number of pathologist by which the quality of
the service increased the case detection rate as well as
the number of patients compared to the previous years.
Previously there was no or one off and on type of path-
ologist but recently there are at least three actively work-
ing pathologists which might contribute for increased
case detection rate.This study tried to assess yet untouched area in the
study site. It is very valuable and informative which
could give insights for health professionals and policy
makers to address the problem. The HIV status of
patients with TB (prior emphasis for EPTB) should have
to be checked and documented. We couldn’t able to
include other socio demographic variables which has
contribution for tuberculous because of incomplete
registration. Lack of the two years data in between due
to fire accident on pathology laboratory was also the
dare for generalization to the overall trend prevalence.
Conclusion
The prevalence of TBLN in patients with lymph node
aspirate in Gondar University Hospital is high. Among
all lymph node sites, cervical region was the predomin-
antly affected site compared to other sites. Female pa-
tients were more affected than males. It is important for
pathologists to be conscious of tuberculous cases when-
ever they encounter enlarged lymph node region. The
HIV status of patients with TB (prior emphasis for
EPTB) should have to be checked and documented. Fur-
ther prospective and advanced studies are recommended
to determine the specific etiologic agents and contribut-
ing factors of TBLN in the study area.
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